MEDNAX, Inc. (MD) CEO Mark Ordan on Q3 2020 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q3: 2020-11-06 Earnings Summary

EPS of $0.37 misses by $0.03
 | Revenue of $460.64M (-48.17% Y/Y) misses by $74.76M

MEDNAX, Inc. (NYSE:MD) Q3 2020 Earnings Conference Call November 6, 2020 9:00 AM ET

Company Participants

Charles Lynch - VP of Strategy and IR
Mark Ordan - CEO
Marc Richards - EVP & CFO
Roger Hinson - President, Pediatrix and Obstetrix Medical Groups

Conference Call Participants

A.J. Rice - Credit Suisse
Brian Tanquilut - Jefferies
Gary Taylor - JP Morgan
Whit Mayo - UBS
Kevin Fischbeck - Bank of America
Nick Spiekhout - William Blair
Pito Chickering - Deutsche Bank
Ralph Giacobbe - Citi

Operator

Ladies and gentlemen, thank you for standing by and welcome to the MEDNAX Third Quarter 2020 Earnings Conference Call. At this point, all participant lines are in a listen-only mode. However, there will be an opportunity for your questions. [Operator Instructions] As a reminder, today's call is being recorded.

I'll turn the conference now to Mr. Charles Lynch, Vice President of Strategy and Investor Relations. Please go ahead, sir.

Charles Lynch

Thanks and good morning, everyone. I quickly read our forward-looking statements and then turn the call over to Mark. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's most recent annual report on Form 10-K, its quarterly reports

Recommended For You

About MD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MD